This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biotech

Teva Pharmaceuticals (TEVA) Stock Gains Today on Mylan Takeover Talk

Teva Pharmaceuticals (TEVA) Stock Gains Today on Mylan Takeover Talk

  • Tickers in this article:
  • TEVA

Teva Pharmaceuticals (TEVA) shares spike following reports that it is considering a bid for Mylan.

04/17/15 - 03:52 PM EDT

Mylan (MYL) Stock Spikes in Afternoon Trading on Teva Takeover Speculation

  • Tickers in this article:
  • MYL

Mylan (MYL) shares are rising following reports that Teva is gearing up for an acquisition bid, although the company has denied interest in any such deal.

04/17/15 - 03:35 PM EDT

Akebia Therapeutics (AKBA) Stock Declines Following Pricing of Secondary Offering

Akebia Therapeutics (AKBA) Stock Declines Following Pricing of Secondary Offering

  • Tickers in this article:
  • AKBA

Akebia Therapeutics (AKBA) shares are falling after the company announced the pricing of its secondary public offering at $8.25 per share.

04/17/15 - 03:14 PM EDT

Rosseta Genomics (ROSG) Stock Continues To Climb Today on Analyst Upgrade

Rosseta Genomics (ROSG) Stock Continues To Climb Today on Analyst Upgrade

  • Tickers in this article:
  • ROSG

Rosseta Genomics (ROSG) shares are climbing after analysts at Cantor upgraded the stock to 'buy' from 'hold' today.

04/17/15 - 12:56 PM EDT

GE Shows It's Moving Quickly to Focus on Industrial Projects

GE Shows It's Moving Quickly to Focus on Industrial Projects

  • Tickers in this article:
  • GE

General Electric appears to be following through with its promise to become a pure industrial powerhouse.

04/17/15 - 11:08 AM EDT

Buy These 4 High-Yield Dividend Stocks to Take Advantage of the Health Care Boom

Buy These 4 High-Yield Dividend Stocks to Take Advantage of the Health Care Boom

Health care stocks are up 33% over the last 12 months, nearly doubling the return of the S&P 500.

04/17/15 - 08:51 AM EDT

Biotech Stock Mailbag: Bluebird's Sickle Cell Data, Ariad's Faux Suitors, XBiotech Blech

Biotech Stock Mailbag: Bluebird's Sickle Cell Data, Ariad's Faux Suitors, XBiotech Blech

Biotech columnist Adam Feuerstein answers readers' questions about health care.

04/17/15 - 05:59 AM EDT

Horizon Pharma (HZNP) Stock Rises in After-Hours Trading Following Pricing of Secondary Offering

Horizon Pharma (HZNP) Stock Rises in After-Hours Trading Following Pricing of Secondary Offering

  • Tickers in this article:
  • HZNP

Horizon Pharma (HZNP) shares are climbing in after-hours trading today after the company priced its secondary public offering at $28.25 per share.

04/16/15 - 04:35 PM EDT

Hedge Fund Manager Mark Yusko Bullish on China, Japan, and Russia

Hedge Fund Manager Mark Yusko Bullish on China, Japan, and Russia

Hedge Fund Manager Mark Yusko finds select opportunities in the U.S. market in healthcare, airlines and cruise lines, and technology stocks like Netflix (NFLX) and Priceline (PCLN).

04/16/15 - 04:01 PM EDT

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Mylan's deal to buy Perrigo is taking another potential target off the block.

04/16/15 - 10:04 AM EDT

If SpaceX CEO Musk was Biotech CEO, Rocket's 'Landing' Big Win

If SpaceX CEO Musk was Biotech CEO, Rocket's 'Landing' Big Win

In which Musk learns how to put a happy spin on failure from biotech CEOs.

04/16/15 - 09:07 AM EDT

Cancer Immunotherapy Remains Hot as Aduro Biotech Doubles in Value On IPO Debut

Cancer Immunotherapy Remains Hot as Aduro Biotech Doubles in Value On IPO Debut

Aduro Biotech shares doubled in value Wednesday following a successful initial public offering -- another sign that investor demand for cancer immunotherapy stocks remains strong.

04/15/15 - 11:35 AM EDT

Teva, Actavis, Other Giants Set to Battle for Generics Space

Teva, Actavis, Other Giants Set to Battle for Generics Space

Teva, Actavis and other generics giants may start preying on each other.

04/15/15 - 11:30 AM EDT

BioLife Solutions (BLFS) Stock Spikes Today on Preliminary Financial Results

BioLife Solutions (BLFS) Stock Spikes Today on Preliminary Financial Results

  • Tickers in this article:
  • BLFS

BioLife Solutions (BLFS) shares are up double digits after the company released preliminary financial results today.

04/14/15 - 12:22 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs